Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people notice Wegovy starting to work within the first week or two, as appetite softens and portions feel smaller, but meaningful weight loss builds over months rather than days. In the STEP 1 trial, semaglutide 2.4mg produced around 15% average weight reduction over 68 weeks. Wegovy is a prescription-only medicine, and a prescriber decides whether it suits you after a clinical assessment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The earliest sign for most people isn't the scales at all. It's a quieter appetite. Wegovy is semaglutide, a GLP-1 receptor agonist made by Novo Nordisk, and it works partly by slowing how quickly your stomach empties and by acting on the appetite signals in your brain. That's why many people describe feeling full sooner and thinking about food less within the first week or two of starting.
Here's the important caveat. You begin on the lowest 0.25mg dose, which exists to let your system settle rather than to drive weight loss. The first pen's real job is helping your body get used to the medicine and easing the risk of nausea. So a gentle appetite shift early on is normal and encouraging, but it isn't the full picture.
People often ask how long Wegovy takes to work in the sense of feeling it, versus seeing results on the scales. The two are different things, and we cover the appetite side in more detail on our page about how long semaglutide takes to suppress appetite. If you feel almost nothing in week one, that's also within the normal range at a starter dose. Response varies from person to person, and the NHS notes that side effects and effects alike tend to be most noticeable when you start or move up a dose.
The honest summary: something usually happens early, but the low starting dose means the first fortnight is about tolerance, not transformation.
Weight loss on Wegovy tends to follow the dose. Because you start at 0.25mg and step up roughly every four weeks through 0.5mg, 1.0mg, 1.7mg and toward the higher maintenance doses, the medicine's appetite effect strengthens over your first few months rather than switching on at once. Many people see the first clear downward trend on the scales within four to eight weeks, though this is an average and not a promise.
Trial data gives the fairest reference point. In STEP 1, published in the New England Journal of Medicine, participants on semaglutide 2.4mg lost around 15% of their body weight over 68 weeks alongside diet and activity changes. The curve in that study kept falling for most of the year before levelling off, which tells you the pattern to expect: steady loss that continues while you titrate and reach your maintenance dose.
If you'd like a month-by-month sense of the early phase, we've written about Wegovy first-month results and, separately, how long it takes to lose weight on Wegovy across the whole course. Both lean on the same evidence base described in the STEP programme.
One steadying thought. Fast early loss isn't the goal, and it isn't the marker of success either. A gradual, sustained decline is what the trials rewarded, and it's what tends to hold.
The slow build is deliberate, not a delay. Wegovy uses a stepped schedule that starts at 0.25mg and rises about every four weeks under a prescriber's guidance, and each step gives your body time to adjust before the next increase. The point is tolerability. Semaglutide's most common side effects are gastrointestinal, and easing the dose upward keeps those milder.
Those side effects, when they appear, are usually nausea, an unsettled stomach, mild diarrhoea or constipation, reflux, burping, tiredness or headache. The NHS describes them as typically most noticeable after starting or increasing a dose, often settling within days to a couple of weeks. Reaching a therapeutic dose gradually is what makes that easier to live with.
This is also why the timeline stretches. If your prescriber judges that you need more time at a given step, your climb to a fuller effect will be a little longer, and that's a clinically sound decision rather than a setback. The semaglutide timeline explained follows this same stepped logic across the different brands and formats.
It's worth knowing that dosing decisions, including when to move up and when to hold, sit with a prescriber and the Patient Information Leaflet, never with a webpage. We don't give you a schedule to follow here. What we can say plainly is that the months-long build is designed to protect your comfort, and the reward is a medicine you can stay on long enough for it to do its work.
Several ordinary things affect how quickly Wegovy shows results. Where you are in the dose schedule matters most: at 0.25mg or 0.5mg you're still building up, so muted results are expected. Beyond that, your starting weight, your metabolism, sleep, stress, other medicines and how much your eating and activity change alongside the injection all play a part. Weight is a health condition shaped by biology, not a test of willpower, and progress rarely runs in a straight line.
A common worry is a stall after early loss. Plateaus happen, and they don't automatically mean the medicine has stopped helping. Sometimes it's a natural pause, sometimes it's a sign you'd benefit from reviewing your dose stage or your day-to-day habits with a clinician. We look at this properly on our page about why you might not be losing weight on Wegovy, and separately at what to consider when Wegovy doesn't seem to be working.
NICE guidance offers a useful benchmark here. In its appraisal of semaglutide, the reference point is roughly 5% weight loss after six months on the maintenance dose; if that isn't reached, it's a prompt to review, not to panic. That's a clinical checkpoint, and it assumes you've had the time to reach and settle on your full dose first.
If results feel slower than you hoped, the most useful step is rarely to abandon the plan. It's to check where you are in the schedule and what else could be nudged.
People weighing up their options often ask whether one medicine works faster than the other. The evidence points to tirzepatide, sold in the UK as Mounjaro, producing greater average weight reduction than semaglutide 2.4mg. In the SURMOUNT-5 head-to-head trial published in the New England Journal of Medicine in 2025, tirzepatide led on average weight change over 72 weeks. So on the size of the eventual result, Mounjaro edged ahead in that study.
Speed is a slightly different question from total loss, though. Both medicines start low and titrate upward over weeks, so neither delivers its full effect overnight, and both follow a comparable early rhythm of appetite change first, scale movement after. The newer higher-dose Wegovy 7.2mg, approved by the MHRA in 2026, narrows the gap on total weight loss reported in trials, at around 20.7% over 72 weeks.
Which suits you isn't decided by the trial averages alone. It depends on your health history, how you tolerate the medicine, your dose response and what a prescriber judges appropriate after assessment. You can read a fuller picture of Wegovy weight-loss results to set expectations before you compare.
The takeaway is measured. Mounjaro tends to produce more loss on average in the studies, but the fastest medicine on paper isn't automatically the right one for a given person. That call belongs in a clinical conversation.
Wegovy's effect continues for as long as you're taking it at an effective dose, which is why the trials ran across many months rather than weeks. In STEP 1, weight loss built steadily before reaching a plateau later in the study, and that plateau is a normal part of the journey rather than a failure. Reaching a stable weight and holding it is a legitimate outcome.
It's worth being straightforward about what stopping does. Semaglutide manages appetite while it's in your system; when treatment ends, appetite tends to return, and some regain is common without other changes in place. If you're curious about the pharmacology, we cover how long Wegovy stays in your system after a dose. This is one reason weight-loss medicines are generally viewed as long-term tools rather than short courses.
On the NHS, semaglutide is recommended by NICE only within a specialist weight management service and for a maximum of two years, which shapes how it's used in that setting. Private treatment through a regulated online pharmacy follows the licensed indication and a prescriber's ongoing review instead. Either way, the medicine works alongside reduced-calorie eating and increased activity, not in place of them.
The realistic frame is this. Wegovy keeps helping while you take it and stay engaged with the lifestyle side, and the longer-term plan, including how and whether to continue, is something to keep reviewing with your clinician rather than deciding alone.
Before Wegovy can work at all, you need a legitimate route to it, because it's a prescription-only medicine that requires a clinical assessment. There's no shortcut around that, and no responsible pharmacy offers these medicines without a prescription or without a proper review. Verifying any online pharmacy on the General Pharmaceutical Council register is a sensible first move, and the MHRA has warned repeatedly about fake weight-loss pens sold on social media, some of which have caused real harm.
At nume we're a GPhC-registered online pharmacy, and every consultation is read by a named Independent Prescriber the same day, never handled by software. If you're clinically suitable, treatment is dispatched the same day when you order before the 12pm cut-off, then delivered free the next working day by DPD in plain, tracked packaging. You can slot that around the school run rather than a pharmacy queue.
Practically, this means the clock on "how long until Wegovy works" starts once you've been assessed and started your first pen. If you want to understand the access side, we explain how long it takes to get Wegovy from consultation to doorstep. Everything sits under one transparent price with priority aftercare seven days a week and no subscription.
We're deliberately not the cheapest, and for a prescription medicine that's the point. A small saving isn't the measure that keeps you safe. Genuine supply, a real prescriber and proper follow-up are.
Related questions we've answered
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.